Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Groen

Showing results (481-490 of 565) with videos related to

Pageof 57
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Randomized, placebo-controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase-2 expression as a biomarker for patients with advanced non-small-cell lung cancer: the NVALT-4 studyHarry J M Groen, Hannie Sietsma, Andrew Vincent, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2022
ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMAJordi Remon, Benjamin Lacas, Roy Herbst, et al.
World Neurosurgery|July 16, 2023
The Diagnostic Value of Near-Infrared Spectroscopy to Predict Delayed Cerebral Ischemia and Unfavorable Outcome After Subarachnoid HemorrhageJ Joep van der Harst, Jan Willem J Elting, Reinoud P H Bokkers, et al.
The Lancet. Oncology|April 16, 2016
Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trialDavid Planchard, Tae Min Kim, Julien Mazieres, et al.
Journal of Neuro-Oncology|February 20, 2025
Neurocognitive function in lower grade glioma patients selected for proton radiotherapy: real-world data from a prospective cohort studyHiska L van der Weide, Anne M Buunk, Femke F Siebenga, et al.
JCO Precision Oncology|January 7, 2022
Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Immune Checkpoint InhibitorsSabrina Weber, Paul van der Leest, Hylke C Donker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2022
Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancerWillem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
European Journal of Neurology|October 13, 2021
The predictive value of the CTA Vasospasm Score on delayed cerebral ischaemia and functional outcome after aneurysmal subarachnoid hemorrhageJ Joep van der Harst, Gert-Jan R Luijckx, Jan Willem J Elting, et al.
Biomed Research International|April 16, 2014
The dopaminergic reward system and leisure time exercise behavior: a candidate allele studyCharlotte Huppertz, Meike Bartels, Maria M Groen-Blokhuis, et al.
Atherosclerosis|April 9, 2013
Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarctionJessica van Setten, Ivana Isgum, Joanna Smolonska, et al.
Pageof 57

Showing results (481-490 of 565) with videos related to

Sort By:
Pageof 57
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Randomized, placebo-controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase-2 expression as a biomarker for patients with advanced non-small-cell lung cancer: the NVALT-4 studyHarry J M Groen, Hannie Sietsma, Andrew Vincent, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2022
ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMAJordi Remon, Benjamin Lacas, Roy Herbst, et al.
World Neurosurgery|July 16, 2023
The Diagnostic Value of Near-Infrared Spectroscopy to Predict Delayed Cerebral Ischemia and Unfavorable Outcome After Subarachnoid HemorrhageJ Joep van der Harst, Jan Willem J Elting, Reinoud P H Bokkers, et al.
The Lancet. Oncology|April 16, 2016
Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trialDavid Planchard, Tae Min Kim, Julien Mazieres, et al.
Journal of Neuro-Oncology|February 20, 2025
Neurocognitive function in lower grade glioma patients selected for proton radiotherapy: real-world data from a prospective cohort studyHiska L van der Weide, Anne M Buunk, Femke F Siebenga, et al.
JCO Precision Oncology|January 7, 2022
Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Immune Checkpoint InhibitorsSabrina Weber, Paul van der Leest, Hylke C Donker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2022
Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancerWillem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
European Journal of Neurology|October 13, 2021
The predictive value of the CTA Vasospasm Score on delayed cerebral ischaemia and functional outcome after aneurysmal subarachnoid hemorrhageJ Joep van der Harst, Gert-Jan R Luijckx, Jan Willem J Elting, et al.
Biomed Research International|April 16, 2014
The dopaminergic reward system and leisure time exercise behavior: a candidate allele studyCharlotte Huppertz, Meike Bartels, Maria M Groen-Blokhuis, et al.
Atherosclerosis|April 9, 2013
Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarctionJessica van Setten, Ivana Isgum, Joanna Smolonska, et al.
Pageof 57